Work

P235 Best-worst scaling analysis of priorities for participation in gene therapy clinical trials for Duchenne muscular dystrophy

Year: 2023

Type: conference-abstract

Source: Neuromuscular Disorders

DOI: 10.1016/j.nmd.2023.07.421

Authors: M. McNiff, E. Heslop, B. Denger, C. Hill, H. Cope, E. Camino, A. Johnson, R. Fischer, H. Peay

Institutions: Newcastle upon Tyne Hospitals NHS Foundation Trust, Parent Project Muscular Dystrophy, RTI International, Duchenne UK

Language: English

Topic: Ethics in Clinical Research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387301800

Cites:

Cited by:

Related to: 10